DexTech Medical AB
Develops drug candidates for urological oncology, focusing on prostate cancer.
DEX | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0005881489
- LEI:
- 549300O3OL7X6EWKLO53
- Country:
- Sweden
- Address:
- Box 389, 752 23 Uppsala
- Website:
- https://dextechmedical.com/
- Sector:
- Manufacturing
Description
DexTech Medical AB is a research company that specializes in developing drug candidates for urological oncology, with a primary focus on prostate cancer. The company utilizes its proprietary GUA-Dex carbohydrate platform to develop carbohydrate-drug-conjugate (CDC) therapies. Its operations encompass translational research, with expertise in clinical oncology, pre-clinical research, and process development for drug manufacturing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all DexTech Medical AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DexTech Medical AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DexTech Medical AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
